20559-16-4CCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)([O-])OCC[N+](C)(C)CVXUOFDJKYGDUJI-OAQYLSRUSA-N1-myristoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine 14:0 in which the acyl group specified is myristoyl. The major species at pH 7.3. It is a 1-O-acyl-sn-glycero-3-phosphocholine, a lysophosphatidylcholine 14:0 and a tetradecanoate ester.
Lipids -> Unambiguous Lipids
Lipids -> Glycerophospholipids [GP] -> Glycerophosphocholines [GP01] -> Monoacylglycerophosphocholines [GP0105]
225.1 Ų [M+Na]+ [CCS Type: DT; Buffer gas: N2; Sample Type: Human plasma; Dataset: Unambiguous Lipids]
227 Ų [M+HCOO]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
227.56 Ų [M+Na]+ [CCS Type: TIMS; Method: single field calibrated]
222 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]
231.3 Ų [M+HCOO]- [CCS Type: TIMS; Method: calibrated with 4 ions from ESI LC/MS tuning mix (Agilent)]
220.8 Ų [M+H]+ [CCS Type: TW; Method: calibrated with phosphatidylcholines (ESI+) and phosphatidylethanolamines (ESI-)]
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Description1-MYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE is a lysophospholipid (LyP), which is a monoglycerophospholipid in which the phosphorylcholine moiety occupies the glycerol substitution site. LysoPC(14:0/0:0) has a potent antispasmodic effect.
Uses1-Myristoyl-sn-glycero-3-phosphocholine is a derivative of sn-Glycero-3-phosphocholine (G598700) and can be used as a biomarker in biological studies.
No reaction records under the current filter.
Loading…
20559-16-4DTXSID90942748CHEMBL462723CHEBI:64489DefinitionChEBI: 1-myristoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine 14:0 in which the acyl group specified is myristoyl. The major species at pH 7.3. It is a lysophosphatidylcholine 14:0, a 1-O-acyl-sn-glycero-3-phosphocholine and a tetradecanoate ester.